Iovance Biotherapeutics Inc (IOVA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Sales | 482 | 469 | 238 | 0 | 0 |
| Cost of Goods | -5,357 | 4,340 | 2,050 | N/A | N/A |
| Gross Profit | 5,839 | -3,871 | -1,812 | N/A | N/A |
| Operating Expenses | 126,738 | 114,830 | 108,324 | 110,856 | 107,036 |
| Operating Income | -121,256 | -118,361 | -110,086 | -110,856 | -107,036 |
| Other Income | 3,118 | 3,358 | 3,081 | 3,486 | 1,717 |
| Pre-tax Income | -118,138 | -115,003 | -107,005 | -107,370 | -105,319 |
| Income Tax | -1,759 | -1,243 | -477 | N/A | N/A |
| Net Income Continuous | -116,379 | -113,760 | -106,528 | -107,370 | -105,319 |
| Net Income | $-116,379 | $-113,760 | $-106,528 | $-107,370 | $-105,319 |
| EPS Basic Total Ops | -0.46 | -0.46 | -0.47 | -0.50 | -0.65 |
| EPS Basic Continuous Ops | -0.45 | -0.46 | -0.47 | -0.50 | -0.64 |
| EPS Diluted Total Ops | -0.46 | -0.46 | -0.47 | -0.50 | -0.65 |
| EPS Diluted Continuous Ops | -0.45 | -0.46 | -0.47 | -0.50 | -0.64 |
| EBITDA(a) | $-113,269 | $-110,364 | $-101,267 | $-106,137 | $-101,983 |